000			01925 a2200505 4500
005			20250515155154.0
264		0	_c20091007
008			200910s 0 0 eng d
022			_a1460-2377
024	7		_a10.1093/intimm/dxn139 _2doi
040			_aNLM _beng _cNLM
100	1		_aJamali, Abbas
245	0	0	_aA novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. _h[electronic resource]
260			_bInternational immunology _cMar 2009
300			_a217-25 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCytotoxicity, Immunologic _xdrug effects
650	0	4	_aHerpes Simplex _ximmunology
650	0	4	_aHerpesvirus 1, Human _ximmunology
650	0	4	_aHypersensitivity, Delayed _xprevention & control
650	0	4	_aImmunity, Cellular _xdrug effects
650	0	4	_aImmunization, Secondary
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNaloxone _xadministration & dosage
650	0	4	_aNarcotic Antagonists _xadministration & dosage
650	0	4	_aT-Lymphocytes, Cytotoxic _xcytology
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aVaccines, DNA _xadministration & dosage
650	0	4	_aViral Envelope Proteins _xadministration & dosage
700	1		_aMahdavi, Mehdi
700	1		_aHassan, Zuhair Muhammad
700	1		_aSabahi, Farzaneh
700	1		_aFarsani, Mohammad Jazayeri
700	1		_aBamdad, Taravat
700	1		_aSoleimanjahi, Hoorieh
700	1		_aMotazakker, Morteza
700	1		_aShahabi, Shahram
773	0		_tInternational immunology _gvol. 21 _gno. 3 _gp. 217-25
856	4	0	_uhttps://doi.org/10.1093/intimm/dxn139 _zAvailable from publisher's website
999			_c18620602 _d18620602